Ophélia Godin is an epidemiologist by training, recently recruited at INSERM as a CRCN researcher at the Mondor Institute for Biomedical Research in Marion Leboyer’s team “Translational Psychiatry”. She did her thesis in Public Health at the University of Paris 11 on the cerebral modifications visible on MRI of dementia in the elderly and has […]
Read more
The management of the EFS has recently published an article highlighting 4 former UPEC Master 2 students (Marion Pinheiro, Louise Pannetier, Latifa Ben Hassen and Justine Coombs) who did their internship with the France Pirenne team of our Institute. Supervised by Benoît Vingert and Marie Tamagne, their research work on post-transfusion alloimmunization has resulted […]
Read more
Topotecan is currently the only drug approved in Europe in a second-line setting for the treatment of small cell lung cancer. This study led by Prof. Christos Chouaid (Department of Pneumology at the CHI de Créteil – IMRB U955, Bastuji-Garin team) aimed to determine whether the carboplatin plus etoposide doublet was superior to Topotecan […]
Read more
The largest European initiative to accelerate the development of therapies for COVID-19 and future coronavirus threats was launched in Brussels on August 18. CARE (Corona Accelerated R&D in Europe) is a €77.7 million European public-private consortium of the Innovative Medicines Initiative (IMI) created to accelerate the development of therapies for Covid-19 and coronaviruses. Professor […]
Read more
VRI (Vaccine Research Institute)/ INSERM/UPEC (U955, IMRB) in collaboration with several Inserm and IRD teams has just published a study in Nature Communications on 24 July showing that Ebola survivors suffer serious immune system sequelae two years after their disease. Continuing to wreak havoc in the Democratic Republic of Congo four years after the […]
Read more
The École nationale vétérinaire d’Alfort is pleased to welcome within its new research platform, the Auguste Chauveau building, the start-up “Encefa” to develop a promising scientific partnership in terms of innovation and research on neurodegenerative and inflammatory diseases. The start up “Encefa” integrated, in June, the premises of our platform dedicated to research in […]
Read more
There’s more news on the Imaging Platform. The platform has installed a staining automaton (Gemini AS) for histology. During September, new staining will be possible: the Sirius Red coloration, the coloration of May-Grünwald Giemsa, the coloration in Periodic Acid Shiff. the Haematoxylin Eosin staining will also be performed with the automaton. Sirius […]
Read more
The molecular cause of sickle cell disease is the polymerization of mutant hemoglobin S during deoxygenation, which is the cause of the multiple attacks of the disease. The amount of fibres in equilibrium and the kinetics of fibre formation both depend on the concentration of haemoglobin S and the partial pressure of oxygen. Pablo […]
Read more
The imaging facility is pleased to announce the arrivals of its new Zeiss LSM 900 confocal microscope with Airyscan2 to replace the LSM510. The LSM 900 will be operational as of June 22nd. The Zeiss confocal LSM 900 is part of the latest Zeiss confocal family. The wide range of objectives (long working distance […]
Read more
The family Bunyaviridae is a large but unfamiliar group of viruses with more than 300 members with a spherical and helical envelope. Viruses of this family can infect a wide range of hosts, from mosquitoes to marsupials and from thrips to tomatoes. Several of the Bunyaviridae cause serious disease in humans; they represent a growing […]
Read more
SVS (Sciences et Vie de la Santé) Doctoral School provides the thesis projects proposed by certain teams of our Institute, among others. Here are the titles with the respective leaders and their associated teams. 1) Cellular origin of spine deformity in a new murine model of Neurofibromatosis type 1 (Céline Colnot, équipe Relaix) 2) […]
Read more
UPEC’s EUR (University Research School) LIVE (Life Trajectories & Health Vulnerability) is calling for applications for doctoral scholarships in the following Doctoral Schools, ED Life and Health Sciences (SVS), ED Organisations, Markets, Institutions (OMI), ED Sciences, Engineering and Environment (SIE) and ED Public Health (SP). Together, UPEC, Inserm and CNRS will study health vulnerability […]
Read more
ISO 9001 certification defines a series of requirements concerning the implementation of a quality management system in an organization, whatever its size and sector of activity. In 2011 the flow cytometry platform was the first platform to receive this certification as well as the processes supporting maintenance and health & safety, followed three years […]
Read more
Hepatocellular carcinoma is responsible for one third of cancer deaths worldwide, and most often develops in a context of chronic inflammation. While the immune microenvironment of tumours plays a decisive role in their evolution and is the subject of numerous studies, the role of immunity during the early stages of carcinogenesis remains little studied. In […]
Read more
Predicting the prognosis of cancers is very important for adapting treatment regimens. A study conducted under the direction of Dr. Julien Calderaro (Pawlotsky Team),
Read more
Ciliary dyskinesia are a group of heterogeneous diseases characterized by an alteration of the respiratory ciliary beating that may induce a degradation of the mucociliary clearance which is the first line of defense of the respiratory system..
Read more
